Related references
Note: Only part of the references are listed.Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status
AmirReza Hesari et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Curcumin: A new candidate for retinal disease therapy?
Hasan Farajipour et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis
Pouria Khani et al.
JOURNAL OF NEUROCHEMISTRY (2019)
MiR-21: A key player in glioblastoma pathogenesis
Mohammad Sadegh Masoudi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes
Zarrin Banikazemi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
MicroRNA: A novel target of curcumin in cancer therapy
Hamed Mirzaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Effects of curcumin on NF-κB, AP-1, and Wnt/β-catenin signaling pathway in hepatitis B virus infection
AmirReza Hesari et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
Yahua Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer
Afsane Bahrami et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Therapeutic Potential of Targeting Wnt/-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
Afsane Bahrami et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Hamed Mirzaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Can curcumin and its analogs be a new treatment option in cancer therapy?
H. Mirzaei et al.
CANCER GENE THERAPY (2016)
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
L. Saadatpour et al.
CANCER GENE THERAPY (2016)
Curcumin: A new candidate for melanoma therapy?
Hamed Mirzaei et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling
Haitao Yin et al.
ONCOLOGY REPORTS (2014)
Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer
Ritu Arora et al.
PLOS ONE (2014)
The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma
Alfeu Zanotto-Filho et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors
Kah Jing Lim et al.
CANCER BIOLOGY & THERAPY (2011)
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine
Madhuri Kakarala et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Aberrant constitutive activation of nuclear factor κB in glioblastoma multiforme drives invasive phenotype
Baisakhi Raychaudhuri et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFκB transcription factors
Krishnan M. Dhandapani et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Curcurnin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells
Surajit Karmakar et al.
NEUROSCIENCE LETTERS (2006)
Antiproliferative effect of quercetin in the human U138MG glioma cell line
Elizandra Braganhol et al.
ANTI-CANCER DRUGS (2006)
Tumor necrosis factor-α-induced protein 3 as a putative regulator of nuclear factor-κB-mediated resistance to O6-alkylating agents in human glioblastomas
M Bredel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
MD Prados et al.
NEURO-ONCOLOGY (2006)
Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
BB Aggarwal et al.
CLINICAL CANCER RESEARCH (2005)
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells
MS Woo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization
SV Bava et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines
ME Halatsch et al.
JOURNAL OF NEUROSURGERY (2004)
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation
A Mukhopadhyay et al.
ONCOGENE (2002)
Aberrant nuclear factor-κB activity and its participation in the growth of human malignant astrocytoma
S Nagai et al.
JOURNAL OF NEUROSURGERY (2002)
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
SE Chuang et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The multilayered postconfluent cell culture as a model for drug screening
JM Padrón et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Share Paper
